These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23157626)

  • 1. Recent developments in neurochemical imaging in schizophrenia: an update.
    Vyas NS; Patel NH; Herscovitch P; Puri BK; Lanzenberger R
    Curr Med Chem; 2013; 20(3):351-6. PubMed ID: 23157626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical imaging in schizophrenia.
    Urban N; Abi-Dargham A
    Curr Top Behav Neurosci; 2010; 4():215-42. PubMed ID: 21312402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glutamate hypothesis of schizophrenia: neuroimaging and drug development.
    Egerton A; Stone JM
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1500-12. PubMed ID: 22283750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Background and findings of neuroimaging in schizophrenia: an update].
    Cuevas-Esteban J; Campayo A; Gutiérrez-Galve L; Gracia-García P; López-Antón R
    Rev Neurol; 2011 Jan; 52(1):27-36. PubMed ID: 21246491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of neuroreceptor imaging to psychiatry research.
    Smith GS; Koppel J; Goldberg S
    Psychopharmacol Bull; 2003; 37(4):26-65. PubMed ID: 15131516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurochemistry and neuroendocrinology of schizophrenia: a selective review.
    Lieberman JA; Koreen AR
    Schizophr Bull; 1993; 19(2):371-429. PubMed ID: 8100644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation in nonhuman primates of five PET radiotracers for imaging the serotonin transporters: [11C]McN 5652, [11C]ADAM, [11C]DASB, [11C]DAPA, and [11C]AFM.
    Huang Y; Hwang DR; Narendran R; Sudo Y; Chatterjee R; Bae SA; Mawlawi O; Kegeles LS; Wilson AA; Kung HF; Laruelle M
    J Cereb Blood Flow Metab; 2002 Nov; 22(11):1377-98. PubMed ID: 12439295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study.
    Willeit M; Ginovart N; Graff A; Rusjan P; Vitcu I; Houle S; Seeman P; Wilson AA; Kapur S
    Neuropsychopharmacology; 2008 Jan; 33(2):279-89. PubMed ID: 17406650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical brain imaging investigations of schizophrenia.
    Soares JC; Innis RB
    Biol Psychiatry; 1999 Sep; 46(5):600-15. PubMed ID: 10472414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric update: neuroimaging schizophrenia.
    Kile SJ
    Psychopharmacol Bull; 2007; 40(4):156-67. PubMed ID: 18227785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging as tool to investigate psychoses and antipsychotics.
    Booij J; van Amelsvoort T
    Handb Exp Pharmacol; 2012; (212):299-337. PubMed ID: 23129337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of cross-species PET imaging to assess neurotransmitter release in brain.
    Finnema SJ; Scheinin M; Shahid M; Lehto J; Borroni E; Bang-Andersen B; Sallinen J; Wong E; Farde L; Halldin C; Grimwood S
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4129-57. PubMed ID: 25921033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of the dopamine dysregulation hypothesis of schizophrenia with neuroimaging techniques].
    Szekeres G; Pávics L; Janka Z
    Ideggyogy Sz; 2002 Jul; 55(7-8):226-32. PubMed ID: 12201230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: A review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry.
    Willeit M; Praschak-Rieder N
    Neuroimage; 2010 Nov; 53(3):878-92. PubMed ID: 20399868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging glutamate in schizophrenia: review of findings and implications for drug discovery.
    Poels EM; Kegeles LS; Kantrowitz JT; Slifstein M; Javitt DC; Lieberman JA; Abi-Dargham A; Girgis RR
    Mol Psychiatry; 2014 Jan; 19(1):20-9. PubMed ID: 24166406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET.
    Kim JH; Son YD; Kim JH; Choi EJ; Lee SY; Lee JE; Cho ZH; Kim YB
    Psychiatry Res; 2015 Jan; 231(1):50-7. PubMed ID: 25465315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging in psychiatry: An update.
    Abou-Saleh MT
    J Psychosom Res; 2006 Sep; 61(3):289-93. PubMed ID: 16938503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroimaging in schizophrenia].
    Lanzenberger R; Kasper S
    Fortschr Neurol Psychiatr; 2005 Nov; 73 Suppl 1():S51-9. PubMed ID: 16270245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy.
    Kegeles LS; Humaran TJ; Mann JJ
    Biol Psychiatry; 1998 Sep; 44(6):382-98. PubMed ID: 9777167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions.
    Szabo Z; McCann UD; Wilson AA; Scheffel U; Owonikoko T; Mathews WB; Ravert HT; Hilton J; Dannals RF; Ricaurte GA
    J Nucl Med; 2002 May; 43(5):678-92. PubMed ID: 11994534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.